PortalPublikationen[Complete remission of multiple brain metastases of non-smal...

[Complete remission of multiple brain metastases of non-small cell lung cancer induced by gefitinib monotherapy].

Standard

[Complete remission of multiple brain metastases of non-small cell lung cancer induced by gefitinib monotherapy]. / Müller, Frauke; Riesenberg, Hendrik; Hirnle, Peter; Gehl, Hans-Björn; Düwel, Paul; Görner, Martin.

in: STRAHLENTHER ONKOL, Jahrgang 187, Nr. 12, 12, 2011, S. 826-830.

Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung

Harvard

Müller, F, Riesenberg, H, Hirnle, P, Gehl, H-B, Düwel, P & Görner, M 2011, '[Complete remission of multiple brain metastases of non-small cell lung cancer induced by gefitinib monotherapy].', STRAHLENTHER ONKOL, Jg. 187, Nr. 12, 12, S. 826-830. <http://www.ncbi.nlm.nih.gov/pubmed/22127359?dopt=Citation>

APA

Müller, F., Riesenberg, H., Hirnle, P., Gehl, H-B., Düwel, P., & Görner, M. (2011). [Complete remission of multiple brain metastases of non-small cell lung cancer induced by gefitinib monotherapy]. STRAHLENTHER ONKOL, 187(12), 826-830. [12]. http://www.ncbi.nlm.nih.gov/pubmed/22127359?dopt=Citation

Vancouver

Müller F, Riesenberg H, Hirnle P, Gehl H-B, Düwel P, Görner M. [Complete remission of multiple brain metastases of non-small cell lung cancer induced by gefitinib monotherapy]. STRAHLENTHER ONKOL. 2011;187(12):826-830. 12.

Bibtex

@article{0452ac1c4b014ffd8c9dea23c9ab8087,
title = "[Complete remission of multiple brain metastases of non-small cell lung cancer induced by gefitinib monotherapy].",
abstract = "While the activity of tyrosine kinase inhibitors as the first line treatment for primary tumors in patients with stage IV non-small cell lung cancer and a positive EGF receptor mutation is well known, little data on the efficacy in controlling cerebral metastases are available.",
keywords = "Adult, Humans, Female, Magnetic Resonance Imaging, Radiotherapy Dosage, Neoplasm Staging, Cranial Irradiation, Drug Resistance, Neoplasm, Antineoplastic Agents/*therapeutic use, Adenocarcinoma/pathology/radiotherapy/*secondary, Brain Neoplasms/pathology/radiotherapy/*secondary, Liver Neoplasms/drug therapy/pathology/secondary, Lung Neoplasms/*drug therapy/pathology/radiotherapy, Lymphatic Metastasis/pathology/radiotherapy, Quinazolines/*therapeutic use, Radiotherapy Planning, Computer-Assisted, Adult, Humans, Female, Magnetic Resonance Imaging, Radiotherapy Dosage, Neoplasm Staging, Cranial Irradiation, Drug Resistance, Neoplasm, Antineoplastic Agents/*therapeutic use, Adenocarcinoma/pathology/radiotherapy/*secondary, Brain Neoplasms/pathology/radiotherapy/*secondary, Liver Neoplasms/drug therapy/pathology/secondary, Lung Neoplasms/*drug therapy/pathology/radiotherapy, Lymphatic Metastasis/pathology/radiotherapy, Quinazolines/*therapeutic use, Radiotherapy Planning, Computer-Assisted",
author = "Frauke M{\"u}ller and Hendrik Riesenberg and Peter Hirnle and Hans-Bj{\"o}rn Gehl and Paul D{\"u}wel and Martin G{\"o}rner",
year = "2011",
language = "Deutsch",
volume = "187",
pages = "826--830",
journal = "STRAHLENTHER ONKOL",
issn = "0179-7158",
publisher = "Urban und Vogel",
number = "12",

}

RIS

TY - JOUR

T1 - [Complete remission of multiple brain metastases of non-small cell lung cancer induced by gefitinib monotherapy].

AU - Müller, Frauke

AU - Riesenberg, Hendrik

AU - Hirnle, Peter

AU - Gehl, Hans-Björn

AU - Düwel, Paul

AU - Görner, Martin

PY - 2011

Y1 - 2011

N2 - While the activity of tyrosine kinase inhibitors as the first line treatment for primary tumors in patients with stage IV non-small cell lung cancer and a positive EGF receptor mutation is well known, little data on the efficacy in controlling cerebral metastases are available.

AB - While the activity of tyrosine kinase inhibitors as the first line treatment for primary tumors in patients with stage IV non-small cell lung cancer and a positive EGF receptor mutation is well known, little data on the efficacy in controlling cerebral metastases are available.

KW - Adult

KW - Humans

KW - Female

KW - Magnetic Resonance Imaging

KW - Radiotherapy Dosage

KW - Neoplasm Staging

KW - Cranial Irradiation

KW - Drug Resistance, Neoplasm

KW - Antineoplastic Agents/therapeutic use

KW - Adenocarcinoma/pathology/radiotherapy/secondary

KW - Brain Neoplasms/pathology/radiotherapy/secondary

KW - Liver Neoplasms/drug therapy/pathology/secondary

KW - Lung Neoplasms/drug therapy/pathology/radiotherapy

KW - Lymphatic Metastasis/pathology/radiotherapy

KW - Quinazolines/therapeutic use

KW - Radiotherapy Planning, Computer-Assisted

KW - Adult

KW - Humans

KW - Female

KW - Magnetic Resonance Imaging

KW - Radiotherapy Dosage

KW - Neoplasm Staging

KW - Cranial Irradiation

KW - Drug Resistance, Neoplasm

KW - Antineoplastic Agents/therapeutic use

KW - Adenocarcinoma/pathology/radiotherapy/secondary

KW - Brain Neoplasms/pathology/radiotherapy/secondary

KW - Liver Neoplasms/drug therapy/pathology/secondary

KW - Lung Neoplasms/drug therapy/pathology/radiotherapy

KW - Lymphatic Metastasis/pathology/radiotherapy

KW - Quinazolines/therapeutic use

KW - Radiotherapy Planning, Computer-Assisted

M3 - SCORING: Zeitschriftenaufsatz

VL - 187

SP - 826

EP - 830

JO - STRAHLENTHER ONKOL

JF - STRAHLENTHER ONKOL

SN - 0179-7158

IS - 12

M1 - 12

ER -